Sonde Health develops AI-powered voice biomarker technologies designed for passive health monitoring across mental, cognitive, and respiratory domains. The company’s platform is delivered as enterprise-ready SDKs that integrate voice analysis into existing digital products and services. Its approach treats everyday speech as a scalable source of health-relevant data. Sonde Health positions its technology within digital health infrastructure rather than consumer-facing applications.

The technology analyzes acoustic and temporal features of voice captured during natural speech, without requiring scripted tasks or clinical assessments. Machine learning models extract biomarkers associated with emotional state, cognitive load, and respiratory function. These signals can be collected passively and longitudinally, enabling continuous monitoring with minimal user burden. The SDK-based delivery model supports deployment across diverse devices, languages, and use cases.

Sonde Health targets enterprises, healthcare platforms, and digital health developers seeking to embed voice-based health monitoring into their products. The technology is intended to support screening, monitoring, and population-level insight rather than standalone diagnosis. Its positioning reflects growing interest in voice as an unobtrusive, scalable biomarker for real-world health assessment.